1Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer, 1972,29:252-260.
2L'Hoste RJ Jr, Filippa DA, Lieberman PH, et al. Primary pulmonary lymphomas. A clinicopathologic analysis of 36 cases. Cancer, 1984,54 : 1397-1406.
3Laohaburanakit P, Hardin KA. NK/T cell lymphoma of the lung: a case report and review of literature. Thorax ,2006,61:267-270.
4Greer JP, Kinney MC, Loughran TP Jr. T cell and NK cell lymphoproliferative disorders. Hematology Am Soc Hematol Educ Program,2001, ( 1 ) :259-281.
5Chan JK, Sin VC, Wang KF,et al. Nonnasal lymphoma expressing the natural killer cell marker CD56: a clinicopathologic study of 49 cases of an uncommon aggressive neoplasm. Blood, 1997,89:4501- 4513.
6Jaffe ES, Chan JK, Su IJ, et al. Report of the Workshop on Nasal and Related Extranodal Angiocentric T/Natural Killer Cell Lymphomas. Definitions, differential diagnosis, and epidemiology. Am J Surg Pathol, 1996,20 : 103-111.
7Cadranel J, Wislez M, Antoine M. Primary pulmonary lymphoma. Eur Respir J,2002,20:750-762.
8Lee KS, Kim Y, Primack SL. Imaging of pulmonary lymphomas. AJR Am J Roentgenol, 1997,168:339-345.
9Pinto PS. The CT Halo Sign. Radiology ,2004,230 : 109-110.
10Yamamoto M, Kimura H, Hironaka T, et al. Detection and quantification of virus DNA in plasma of patients with Epstein-Barr virus-associated diseases. J Clin Microbiol, 1995,33 : 1765-1768.
